7 research outputs found
The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region
BACKGROUND:
The cell-cycle inhibitor p57kip2 plays a critical role in mammalian development by coordinating cell proliferation and differentiation in many cell types. p57kip2 expression is finely regulated by several epigenetic mechanisms, including paternal imprinting. Kcnq1ot1, a long non-coding RNA (LncRNA), whose gene maps to the p57Kip2 imprinting domain, is expressed exclusively from the paternal allele and participates in the cis-silencing of the neighboring imprinted genes through chromatin-level regulation. In light of our previous evidence of a functional interaction between myogenic factors and imprinting control elements in the regulation of the maternal p57Kip2 allele during muscle differentiation, we examined the possibility that also Kcnq1ot1 could play an imprinting-independent role in the control of p57Kip2 expression in muscle cells.
RESULTS:
We found that Kcnq1ot1 depletion by siRNA causes the upregulation of the maternal and functional p57Kip2 allele during differentiation, suggesting a previously undisclosed role for this LncRNA. Consistently, Chromatin Oligo-affinity Precipitation assays showed that Kcnq1ot1 physically interacts not only with the paternal imprinting control region of the locus, as already known, but also with both maternal and paternal alleles of a novel p57Kip2 regulatory region, located intragenically and containing two binding sites for the muscle-specific factor MyoD. Moreover, chromatin immunoprecipitation assays after Kcnq1ot1 depletion demonstrated that the LncRNA is required for the accumulation of H3K27me3, a chromatin modification catalyzed by the histone-methyl-transferase EZH2, at the maternal p57kip2 intragenic region. Finally, upon differentiation, the binding of MyoD to this region and its physical interaction with Kcnq1ot1, analyzed by ChIP and RNA immunoprecipitation assays, correlate with the loss of EZH2 and H3K27me3 from chromatin and with p57Kip2 de-repression.
CONCLUSIONS:
These findings highlight the existence of an imprinting-independent role of Kcnq1ot1, adding new insights into the biology of a still mysterious LncRNA. Moreover, they expand our knowledge about the molecular mechanisms underlying the tight and fine regulation of p57Kip2 during differentiation and, possibly, its aberrant silencing observed in several pathologic conditions
Poly(ADP-ribose) Polymerase 1 (PARP1) restrains MyoD-dependent gene expression during muscle differentiation
The myogenic factor MyoD regulates skeletal muscle differentiation by interacting with a variety of chromatin-modifying complexes. Although MyoD can induce and maintain chromatin accessibility at its target genes, its binding and trans-activation ability can be limited by some types of not fully characterized epigenetic constraints. In this work we analysed the role of PARP1 in regulating MyoD-dependent gene expression. PARP1 is a chromatin-associated enzyme, playing a well recognized role in DNA repair and that is implicated in transcriptional regulation. PARP1 affects gene expression through multiple mechanisms, often involving the Poly(ADP-ribosyl)ation of chromatin proteins. In line with PARP1 down-regulation during differentiation, we observed that PARP1 depletion boosts the up-regulation of MyoD targets, such as p57, myogenin, Mef2C and p21, while its re-expression reverts this effect. We also found that PARP1 interacts with some MyoD-binding regions and that its presence, independently of the enzymatic activity, interferes with MyoD recruitment and gene induction. We finally suggest a relationship between the binding of PARP1 and the loss of the activating histone modification H3K4me3 at MyoD-binding regions. This work highlights not only a novel player in the epigenetic control of myogenesis, but also a repressive and catalytic-independent mechanisms by which PARP1 regulates transcription
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells.
Nuclear localization of TRK-A in liver cells
The liver represents a site of expression of
neurotrophins and their receptors. We have characterized
the expression and intracellular localization of the nerve
growth factor (NGF) receptor, Trk-A, in liver cells in
vivo and in vitro. In both normal and fibrotic liver tissue,
Trk-A immunostaining was present in different cell
types, including parenchymal cells and cells of the
inflammatory infiltrate. In hepatocytes and activated
stellate cells (HSC), Trk-A showed a predominant
nuclear localization, both in the presence and absence of
injury. In cultured HSC, Trk-A was found to be
functional, because exposure of the cells to recombinant
NGF resulted in stimulation of cell migration and
activation of intracellular signaling pathways, including
Ras-ERK and PI3K/Akt. Remarkably, in cultured HSC,
Trk-A staining was found constitutively in the nucleus.
In these cells, Trk-A could be stained only by antibodies
directed against the intracellular domain but not by those
recognizing the extracellular portion of Trk-A
suggesting that the intracellular portion of the receptor is
the major determinant of nuclear Trk-A staining. In contrast to HSC, freshly isolated hepatocytes did not
show any nuclear localization of the intracellular portion
of Trk-A. In pheocromocytoma cells, nuclear staining
for Trk-A was not present in conditions of serum
deprivation, but could be induced by exposure to NGF or
to a mixture of soluble mediators. We conclude that
nuclear localization of the intracellular domain of Trk-A
is observed constitutively in liver cells such as HSC,
while in other cell types it could be induced in response
to soluble factors